trending Market Intelligence /marketintelligence/en/news-insights/trending/hrwiy75nf72z2co8r8nydw2 content esgSubNav
In This List

Zai Lab names CFO

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Zai Lab names CFO

Shanghai-based Zai Lab Ltd. appointed Billy Cho CFO.

Cho previously served Citigroup as managing director and head of Asia Healthcare Investment Banking.

Zai Lab is focused on medicines for cancer, autoimmune and infectious diseases for patients in China.